DAVID WEINBERG, M.D.
Medical Practice in Philadelphia, PA

License number

Pennsylvania MD047020L

Personal information

See more information about DAVID WEINBERG at radaris.com

Name

Address

Phone

David Weinberg

500 N Webster Ave APT 313, Scranton, PA 18510

David Weinberg

45 S 6Th St, Columbia, PA 17512

(717) 684-2203

David Weinberg, age 41

3709 Woodridge Dr, Harrisburg, PA 17110

David Weinberg, age 64

4221 Horseshoe Pike, Honey Brook, PA 19344

(610) 273-2835

David T Weinberg, age 50

1338 New Rodgers Rd, Levittown, PA 19056

(215) 752-3577

Organization information

See more information about DAVID WEINBERG at bizstanding.com

David Weinberg MD

333 Cottman Ave, Philadelphia, PA 19111

Industry:

Internist

Site:

fccc.edu

Phone:

(215) 214-1424 (Phone)

Description:

There are 99 doctors at this site. Surgery is not performed at this site.

David Seth Weinberg

Professional information

Dr. David S Weinberg, Philadelphia PA - MD (Doctor of Medicine)

Specialties:

Gastroenterology

Address:

Gastroenterology
333 Cottman Ave, Philadelphia 19111
(215) 214-1475 (Phone)
Fox Chase Cancer Center
333 Cottman Ave, Philadelphia 19111
(215) 728-6900 (Phone)

Procedures:

Colonoscopy, Sigmoidoscopy, Upper Gi Endoscopy

Conditions:

Colonoscopy, Sigmoidoscopy

Certifications:

Gastroenterology, 2006, Internal Medicine, 1992

Awards:

Healthgrades Honor Roll, America's Best Doctors, 2003-Prese, America's Top Doctors for Cancer, 2009-Prese, American Cancer Society Cancer Control Award, 2012, Build It, and Will They Come? Unexpected Findings From a Study on a Web-Based Intervention to Improve Colorectal Cancer Screening, 2012, Molecular staging individualizing cancer management, 2012, Molecular staging individualizing cancer management, 2012

Languages:

English

Hospitals:

Gastroenterology
333 Cottman Ave, Philadelphia 19111
Fox Chase Cancer Center
333 Cottman Ave, Philadelphia 19111
Temple University Hospital
3401 North Broad St, Philadelphia 19140
Fox Chase Cancer Center
333 Cottman Ave, Philadelphia 19111

Philosophy:

I joined the staff at Fox Chase Cancer Center in 2001 as director of gastroenterology. While my gastroenterology colleagues and I see many patients with cancers of all types, we are very happy to care for the gastrointestinal needs of patients without cancer as well.

Education:

Medical School
Joan Sanford I Weill Medical College Of Cornell University
Graduated: 1989
Beth Israel Hospital
Graduated: 1990
Graduated: 1992
University Of Pennsylvania
Graduated: 1995

David C. Weinberg, Philadelphia PA - Lawyer

Office:

Wilbraham, Lawler & Buba A Professional Corporation
1818 Market St SUITE 3100, Philadelphia, PA 19103

Specialties:

Toxic Tort Defense, Medical Malpractice Defense, General Liability Defense, Tractor-Trailer Litigation Defense, Real Estate

Memberships:

New Jersey State and Pennsylvania Bar Associations, Maryland State Bar Association, Inc., Defense Research Institute

ISLN:

902891638

Admitted:

1982,New Jersey, 1983,Pennsylvania, 2000,Maryland

University:

University of Delaware, B.A., 1979

Law School:

Syracuse University College of Law, J.D., 1982

Reported:

Greenleaf v. Garlock Inc, 174 F.2d 352, (1999); Aetna Surety and Casualty v. Sacchetti, 956 F. Supp 1163, (1996); Collins v. Baxter Healthcare, 949 F. Supp 1143, (1996); Junge v. Garlock Inc, 427 Pa. Super 596, 629 A. 2d 1027, (1993).

Biography:

David joined Wilbraham, Lawler & Buba in February 2012. He has significant experience in toxic tort defense, medical malpractice defense, tractor-trailer litigation defense, real estate law and genera...

David C. Weinberg, Philadelphia PA - Lawyer

Address:

Wilbraham, Lawler & Buba, P.C.
1818 Wilbraham Lawler & Buba Pc STE 3100, Philadelphia 19103
(215) 972-2859, (215) 564-4385

Licenses:

Pennsylvania - Active 1983

Education:

Syracuse University College of LawDegree JD

Specialties:

Litigation - 34%
Appeals - 33%
Juvenile - 33%

Managing Director At Penn Hudson

Position:

Managing Director at Penn Hudson

Location:

Greater Philadelphia Area

Industry:

Management Consulting

Work:

Penn Hudson since Nov 1988 - Managing Director

Education:

Cornell University - S.C. Johnson Graduate School of Management
Kenyon College

Skills:

Business Strategy, Management Consulting, Strategic Planning, Financial Modeling, Strategy, Financial Analysis, Risk Management, Restructuring, Mergers & Acquisitions, Business Planning, Due Diligence, Forecasting

Languages:

Spanish

Certifications:

Chartered Financial Analyst (CFA), https://www.cfainstitute.org
Certified Insolvency and Restructuring Advisor (CIRA), https://www.aira.org/cira
Certified Turnaround Professional (CTP), http://www.turnaround.org/Certification/About/default.aspx
Competitive Intelligence Professional (CIP), http://academyci.com/

Attorney At Wilbraham, Lawler &Amp; Buba

Position:

attorney at Wilbraham, Lawler & Buba, attorney at Wilbraham, Lawler & Buba

Location:

Greater Philadelphia Area

Industry:

Law Practice

Work:

Wilbraham, Lawler & Buba since Feb 2012 - attorney

Education:

University of Delaware 1975 - 1979
BA, Political Science Syracuse University
Juris Doctor

Skills:

Toxic Tort, Mass Torts, Product Liability, Premises Liability, Class Actions, Public Liability, Torts

Methods Of Identifying And Detecting Pancreatic Cancer

US Patent:

6187536, Feb 13, 2001

Filed:

Feb 18, 1998

Appl. No.:

9/025534

Inventors:

David Weinberg - Philadelphia PA
Scott A. Waldman - Ardmore PA
Michael T. Barber - Paoli PA
Sanjoy Biswas - Philadelphia PA

Assignee:

Thomas Jefferson University - Philadelphia PA

International Classification:

C12Q 168

US Classification:

435 6

Abstract:

Conjugated compounds which comprises an CCK A receptor binding moiety and a radiostable active moiety are disclosed. Pharmaceutical compositions comprising conjugated compound which comprises an CCK A receptor binding moiety and a radiostable active moiety or an CCK A receptor binding moiety and a radioactive active moiety are disclosed. Methods of treating an individual suspected of suffering from pancreatic cancer are disclosed. Methods of radioimaging pancreatic cancer cells are disclosed. In vitro methods, kits and reagents are disclosed for determining whether or not an individual has pancreatic cancer cells, for determining whether tumor cells are pancreatic in origin and for analyzing tissue samples to evaluate the extent of metastasis of pancreatic tumor cells.